Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 12,506,886
- Total 13F shares
- 110,076
- Share change
- +91,260
- Total reported value
- $2,850,969
- Price per share
- $25.90
- Number of holders
- 4
- Value change
- +$2,337,873
- Number of buys
- 3
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 34962G208?
CUSIP 34962G208 identifies FBRX - Forte Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 34962G208:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. |
13F
13D/G
|
Company |
13%
from 13D/G
|
1,765,516
|
$48,145,621 | — | 31 Dec 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
12%
|
1,460,971
|
$39,840,679 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
11%
from 13D/G
|
1,425,785
|
$39,159,185 | — | 31 Dec 2025 | |
| ORBIMED ADVISORS LLC |
13F
13D/G
|
Company |
8%
from 13D/G
|
1,196,955
|
$32,640,963 | — | 31 Dec 2025 | |
| Affinity Asset Advisors, LLC |
13F
13D/G
|
Company |
6.7%
from 13D/G
|
989,490
|
$26,983,392 | — | 31 Dec 2025 | |
| ALGER ASSOCIATES INC |
13D/G
|
— |
13%
|
1,634,267
|
$24,514,005 | +$234,270 | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13D/G
13F
|
Company |
6.3%
|
792,976
|
$21,132,810 | $0 | 12 Jan 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
582,263
|
$15,878,312 | — | 31 Dec 2025 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
|
— |
10%
|
1,268,086
|
$13,378,307 | +$6,618,184 | 30 Jun 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
3.2%
|
400,000
|
$10,908,000 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
333,333
|
$9,089,991 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.7%
|
331,987
|
$9,053,285 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
2.5%
|
310,965
|
$8,480,016 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
13D/G
|
Company |
5%
from 13D/G
|
300,000
|
$8,181,001 | — | 31 Dec 2025 | |
| Steven Michael Oliveira |
13D/G
|
Oliveira Steven Michael |
2.4%
|
300,100
|
$6,797,265 | -$2,993,786 | 08 Jan 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2%
|
246,685
|
$6,727,100 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.9%
|
236,821
|
$6,458,109 | — | 31 Dec 2025 | |
| Jain Global LLC |
13F
|
Company |
1.6%
|
202,433
|
$5,520,348 | — | 31 Dec 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.5%
|
185,869
|
$5,068,648 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
153,027
|
$4,173,046 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
124,609
|
$3,400,403 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.56%
|
70,531
|
$1,923,381 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
68,023
|
$1,854,987 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.52%
|
64,496
|
$1,758,806 | — | 31 Dec 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.49%
|
60,800
|
$1,658,016 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.42%
|
52,914
|
$1,442,965 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
50,721
|
$1,383,162 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
— |
2.5%
|
163,935
|
$1,209,840 | $0 | 31 Dec 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.32%
|
40,000
|
$1,090,800 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.29%
|
36,297
|
$989,821 | — | 31 Dec 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
0.5%
|
65,350
|
$980,250 | -$8,674,080 | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.26%
|
32,187
|
$877,739 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
31,808
|
$867,404 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
25,441
|
$693,776 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
24,824
|
$676,951 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
24,111
|
$657,507 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13D/G
|
— |
0.8%
|
53,791
|
$567,495 | -$369,187 | 30 Jun 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.16%
|
19,498
|
$531,710 | — | 31 Dec 2025 | |
| AlphaQuest LLC |
13F
|
Company |
0.15%
|
18,804
|
$512,785 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.14%
|
17,573
|
$479,216 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.13%
|
16,542
|
$451,100 | — | 31 Dec 2025 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.13%
|
15,804
|
$430,975 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.12%
|
15,600
|
$425,412 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.12%
|
15,472
|
$421,921 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.1%
|
12,916
|
$352,219 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.1%
|
11,986
|
$327,000 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
11,084
|
$302,261 | — | 31 Dec 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.08%
|
10,289
|
$280,581 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.08%
|
10,146
|
$276,681 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
8,344
|
$227,541 | — | 31 Dec 2025 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock (FBRX) as of Q1 2026
As of 31 Mar 2026,
Forte Biosciences, Inc. - Common Stock (FBRX) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
110,076 shares.
The largest 5 holders included
Candriam S.C.A., ENVESTNET ASSET MANAGEMENT INC, Weil Company, Inc., FIFTH THIRD BANCORP, and SBI Securities Co., Ltd..
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
59
Q1 2026 holders
4
Holder diff
-55
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.